(Press-News.org) New Rochelle, NY, February 11, 2014—An innovative therapeutic strategy for reducing the levels of toxic protein fragments associated with Huntington's disease uses a new approach called exon skipping to remove the disease-causing component of the essential protein, huntingtin. Proof of concept using antisense oligonucleotides to "skip over" the specific exon in a mouse model of Huntington's disease is reported in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article, part of a special focus issue on exon skipping, is available on the Nucleic Acid Therapeutics website.
Melvin Evers et al., Leiden University Medical Center, The Netherlands, describe the successful use of antisense oligonucleotides to target the mutated exon that causes Huntington's disease in the article "Preventing Formation of Toxic N-Terminal Huntingtin Fragments Through Antisense Oligonucleotide-Mediated Protein Modification."
"No field of therapeutic development is moving faster, with more imminent clinical translation than the nucleic acid based treatment of central nervous system conditions," says Executive Editor Graham C. Parker, PhD, The Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Children's Hospital of Michigan, Detroit, MI. "The novel therapeutic strategy outlined in Evers et al. gives us a proof of concept of how a previously intractable condition can be treated by modifying rather than removing the toxic protein."
The special issue also includes the Review article "A Chemical View of Oligonucleotides for Exon Skipping and Related Drug Applications." by Peter Järver, Liz O'Donovan, and Michael Gait, Medical Research Council, Cambridge, U.K. The authors explore the complex chemistry and design of antisense oligonucleotides used for exon skipping and progress in developing new chemistries to improve their stability and binding.
Annemieke Aartsma-Rus, PhD, Leiden University Medical Center, Guest Editor of the issue, emphasizes the need for scientists, clinicians, patients, regulators, and drug manufacturers to work closely together to develop exon skipping therapeutics, which are currently in clinical trials for neuromuscular disorders such as Duchenne muscular dystrophy and spinal muscular atrophy. These complex drugs and the challenging diseases they are targeting require a collaborative effort, she states in her Editorial "Antisense-Mediated Exon Skipping: Networking to Meet Opportunities and to Overcome Challenges."
Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC, and C.A. Stein, MD, PhD, City of Hope National Medical Center, Duarte, CA; and Executive Editor Graham C. Parker, PhD.
INFORMATION:
About the Journal
Nucleic Acid Therapeutics is an authoritative, peer-reviewed journal published bimonthly in print and online that focuses on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. Nucleic Acid Therapeutics is the official journal of the Oligonucleotide Therapeutics Society. Complete tables of content and a free sample issue may be viewed on the Nucleic Acid Therapeutics website.
About the Society
The Oligonucleotide Therapeutics Society is an open, nonprofit forum to foster academia- and industry-based research and development of oligonucleotide therapeutics. The society brings together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many areas of science and biomedical research, including Human Gene Therapy, Human Gene Therapy Methods, Human Gene Therapy Clinical Development, ASSAY and Drug Development Technologies, and DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
Mary Ann Liebert, Inc.
140 Huguenot St., New Rochelle, NY 10801-5215
Phone: (914) 740-2100
(800) M-LIEBERT
Fax: (914) 740-2101
http://www.liebertpub.com
Exon skipping prevents formation of toxic protein fragments in Huntington's disease
2014-02-11
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Excess weight linked to brain changes that may relate to memory, emotions, and appetite
2014-02-11
Being overweight appears related to reduced levels of a molecule that reflects brain cell health in the hippocampus, a part of the brain involved in memory, learning, and emotions, and likely also involved in appetite control, according to a study performed by researchers at SUNY Downstate Medical Center and other institutions. The results of the study were published in Neuroimage: Clinical.
Jeremy D. Coplan, MD, professor of psychiatry at SUNY Downstate, led a multicenter team that visualized the molecule, N-acetyl-aspartate (NAA), using magnetic resonance spectroscopy, ...
RI Hospital: Cognitive behavioral therapy benefits patients with body dysmorphic disorder
2014-02-11
PROVIDENCE, R.I. – In a recent study, researchers at Rhode Island Hospital found significant benefits of cognitive behavioral therapy as a treatment modality for patients with Body Dysmorphic Disorder (BDD). BDD is a common, often severe, and under-recognized body image disorder that affects an estimated 1.7 percent to 2.4 percent of the population. This study demonstrated significant improvement in patients' BDD symptoms and level of disability, as well as high levels of patient satisfaction with the treatment. The study is published online in advance of print in the journal ...
Source of 'moon curse' revealed by eclipse
2014-02-11
Strange events have long been linked to nights of a full moon, though careful scrutiny dispels any association. So, when signals bounced off the lunar surface returned surprisingly faint echoes on full moon nights, scientists sought an explanation in reason rather than superstition. Still, the most compelling evidence arrived during another event that once evoked irrational fears—on a night when Earth's shadow eclipsed the full moon.
Tom Murphy, a physicist at UC San Diego, is among the scientists who have aimed laser beams at suitcase-sized reflectors placed on the moon ...
Study: Resilience in parents of children undergoing stem cell transplant
2014-02-11
A child's illness can challenge a parent's wellbeing. However, a study recently published in the journal Biology of Blood and Marrow Transplantation shows that in the case of a child's stem cell transplant, parents feel increased distress at the time of the procedure, but eventually recover to normal levels of adjustment.
"Across all study groups, what we basically showed is that parents are resilient. Overall, parents get better over time," says Jennifer Lindwall, PhD, assistant professor of psychiatry at the CU School of Medicine, teaching partner of the University ...
Data on today's youth reveal childhood clues for later risk of STDs
2014-02-11
Here's yet another reason to focus on kids' early years. Children who grow up in well-managed households, enjoy school, and have friends who stay out of trouble report fewer sexually transmitted diseases in young adulthood, according to a new analysis.
The findings, from University of Washington longitudinal surveys of nearly 2,000 participants, suggest that efforts to curb the spread of sexually transmitted diseases should begin years before most people start having sex.
"Pay less attention to the sex aspect of this and think of the larger context," is lead author ...
Targeting tumors: Ion beam accelerators take aim at cancer
2014-02-11
EVENT: Advances in the design and operation of particle accelerators built for basic physics research are leading to the rapid evolution of machines that deliver cancer-killing beams. Hear about the latest developments and challenges in this field from a physicist, a radiobiologist, and a clinical oncologist, and participate in a discussion about cost, access, and ethics at a symposium organized by the U.S. Department of Energy's Brookhaven National Laboratory ("Targeting Tumors: Ion Beam Accelerators Take Aim at Cancer") and at a related press briefing--both to be held ...
Nanoparticles treat muscular dystrophy in mice
2014-02-11
Researchers at Washington University School of Medicine in St. Louis have demonstrated a new approach to treating muscular dystrophy. Mice with a form of this muscle-weakening disease showed improved strength and heart function when treated with nanoparticles loaded with rapamycin, an immunosuppressive drug recently found to improve recycling of cellular waste.
The study appears online in The FASEB Journal.
The investigators, including first author Kristin P. Bibee, MD, PhD, looked at a mouse model of Duchenne muscular dystrophy, the most severe inherited form of the ...
Child abuse rises with income inequality, study shows
2014-02-11
ITHACA, N.Y. – As the Great Recession deepened and income inequality became more pronounced, county-by-county rates of child maltreatment – from sexual, physical and emotional abuse to traumatic brain injuries and death – worsened, according to a nationwide study by Cornell University.
The income inequality-child maltreatment study, to be published in the March 2014 edition of the peer-review journal Pediatrics, covers all 3,142 American counties from 2005-09, and is one of the most comprehensive of its kind and the first to target child abuse in places with the greatest ...
I smoke, but I'm not a smoker
2014-02-11
While smoking among California adults has dramatically declined in recent decades, researchers at the University of California, San Diego School of Medicine report there is a surprisingly large number of people who say they use cigarettes, but don't consider themselves to be "smokers."
Writing in the February 5 online issue of Tobacco Control, Wael K. Al-Delaimy, MD, PhD, professor and chief of the Division of Global Health in the UC San Diego Department of Family and Preventive Medicine, and colleagues estimate that, in 2011, almost 396,000 Californians (12.3 percent ...
Dartmouth study provides first global evidence that foreign aid boosts public opinion
2014-02-11
A study by Dartmouth and Australian researchers provides the first empirical evidence using data from a variety of countries that foreign aid can greatly improve foreign public opinion of donor countries.
The findings are based on a U.S. foreign aid program targeting HIV and AIDS -- the President's Emergency Plan for AIDS Relief (PEPFAR) -- that has substantially improved public perception of the United States in the more than 80 developing countries receiving the aid. But the findings have broader policy implications for an emerging international order in which major ...